It is a bad time to be a parasitic worm or tsetse fly. An unprecedented $785 million
is to be invested by governments of rich countries, pharmaceutical
companies and global charities to try to combat tropical diseases
affecting a billion of the world's poorest people.
The
collaboration has pledged this week to provide 14 billion treatments
over the next decade for 10 neglected tropical diseases, including
sleeping sickness, spread by the tsetse fly, leprosy and a host of
debilitating diseases caused by parasitic worms.
"This
is the largest collaborative effort ever to attack an unacceptable
infectious disease burden affecting the world's poor," says James
Kazura, president of the American Society of Tropical Medicine and Hygiene.
"The timing could not be better since the tools to control neglected
tropical diseases are in hand, or soon will be if critical research can
be continued."
Backers of the collaboration, united by a new World Health Organization strategy,
include 13 pharmaceutical companies, the governments of the US, UK and
United Arab Emirates, the Bill and Melinda Gates Foundation and a host
of global health organisations.
Michael Ferguson, who develops treatments for tropical diseases
at the University of Dundee, UK, welcomed the announcement: "The world
is now going in the right direction on this, whereas 10 years ago you
felt no one was listening."
According
to Ferguson, the past few years have seen a "sea change" in attitudes,
with the growth of corporate responsibility, pressure from shareholders
to help the poor and pledges by governments of long-term support for
drug-development projects.
He adds that research is particularly needed to find better treatments for Chagas disease, which is presently incurable.
http://www.newscientist.com/
No comments:
Post a Comment